• Home >
  • Production

    • Single Use

    Single use technologies (SUTs) have become a mainstay in pharma because they reduce the risk of contamination and often offer more flexibility than traditional processing technologies. Generally made from plastic components, SUTs are a common feature of facility design from upstream to downstream processes. 

    Articles

    Psg Biotech Support Image 2
    Critical biopharma applications require protection of media integrity
    shutterstock-572714011
    Either option comes with pros and cons but a hybrid approach may offer greater latitude
    PM2111-HERO-575x327-Supply
    Evolving considerations when choosing between single-use or reusable temperature-controlled packaging
    PM2102-HERO-880x500-Quality
    How purpose-built sensors can help overcome biopharma single-use challenges
    SW213-SW2RFID-Activated-R2V1-07-2-19
    The rise of single-use technologies in pharma has shown no signs of abating and is continuing to transform every area of operations.
    sustainability
    From managing water usage to reducing waste, there are a number of ways pharma companies can refine their processes to reduce their impact on the environment.
    FDA-CDER-2-Downstream-Bioprocessing-00012
    Biopharma needs to address its workforce training methods
    UNVC-NevoLine-2
    This year's winners offer slices of innovation
    AVANTOR-equipment3
    The latest technologies build on past innovations to boost efficiency for manufacturers.
    279116b8-ae0d-40d7-909f-2cf3231a8977
    As single-use technology becomes mainstream, biopharma companies need a better way to handle waste
    Amgen-Singapore-Next-Generation-Biomanufacturing-Manufacturing-3
    Why building smaller manufacturing plants is the next big thing